Hsin‐I Chang
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 13
- Electrospun Nanofibers in Biomedical Applications 6
- Nanoparticle-Based Drug Delivery 6
-
- Advanced Drug Delivery Systems 6
- Co-authors
- Ming−Yen Cheng (2 shared papers)Ming‐Kung Yeh (1 shared paper)Yiwei Wang (7 shared papers)Cheng‐Nan Chen (15 shared papers)Allan G.A. Coombes (4 shared papers)A.G.A. Coombes (3 shared papers)Shun‐Fu Chang (8 shared papers)Mong Song Liang (1 shared paper)
- Journals
- Journal of Cellular Physiology (4 papers)Biomaterials (3 papers)Journal of Drug Delivery Science and Technology (2 papers)Journal of Basic and Clinical Physiology and Pharmacology (2 papers)Journal of Cellular Biochemistry (2 papers)
- Partner nations
- TaiwanAustraliaUnited Kingdom
In The Last Decade
Hsin‐I Chang
49 papers receiving 1.9k citations
Hsin‐I Chang's Hit Papers
Peers
Comparison fields: 5 of 125
- Biomaterials 816
- Pharmaceutical Science 194
- Rehabilitation 91
- Biomedical Engineering 639
- Molecular Medicine 63
Countries citing papers authored by Hsin‐I Chang
This map shows the geographic impact of Hsin‐I Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsin‐I Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsin‐I Chang more than expected).
Fields of papers citing papers by Hsin‐I Chang
This network shows the impact of papers produced by Hsin‐I Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsin‐I Chang. The network helps show where Hsin‐I Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hsin‐I Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy Hit paper breakdown → | 2011 | 719 |
| 2 | 2011 | 334 | |
| 3 | 2010 | 55 | |
| 4 | 2007 | 50 | |
| 5 | 2017 | 46 | |
| 6 | 2007 | 41 | |
| 7 | 2021 | 38 | |
| 8 | 2010 | 37 | |
| 9 | 2011 | 35 | |
| 10 | 2004 | 33 | |
| 11 | 2019 | 30 | |
| 12 | 2005 | 28 | |
| 13 | 2009 | 27 | |
| 14 | 2012 | 24 | |
| 15 | 2010 | 23 | |
| 16 | 2018 | 23 | |
| 17 | 2009 | 22 | |
| 18 | 2013 | 21 | |
| 19 | 2018 | 21 | |
| 20 | 2018 | 20 |
About Hsin‐I Chang
Hsin‐I Chang is a scholar working on Biomaterials, Pharmaceutical Science, Rheumatology, Immunology and Allergy and Pharmacology, having authored 49 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (7 papers), Electrospun Nanofibers in Biomedical Applications (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Osteoarthritis Treatment and Mechanisms (6 papers), Advanced Drug Delivery Systems (6 papers), Cell Adhesion Molecules Research (4 papers), Lipid Membrane Structure and Behavior (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Biomaterials (816 citations), Pharmaceutical Science (194 citations), Rehabilitation (91 citations), Biomedical Engineering (639 citations) and Molecular Medicine (63 citations). Hsin‐I Chang has collaborated with scholars based in Taiwan, Australia and United Kingdom. Frequent co-authors include Ming−Yen Cheng, Ming‐Kung Yeh, Yiwei Wang, Cheng‐Nan Chen, Allan G.A. Coombes, A.G.A. Coombes, Shun‐Fu Chang, Mong Song Liang, Cheng Yan and Ko‐Chao Lee. Their work appears in journals such as Journal of Cellular Physiology, Biomaterials, Journal of Drug Delivery Science and Technology, Journal of Basic and Clinical Physiology and Pharmacology and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.